Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17243 | 546 | 39.6 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | POLYASPARTOYL L ARGININE | Author keyword | 6 | 100% | 1% | 4 |
2 | BEIJING S HYDRONE PEPTIDES | Address | 2 | 67% | 0% | 2 |
3 | CHAIR SEMEIOL MED METHODOL | Address | 2 | 50% | 1% | 3 |
4 | ANAL AVANCADAS BIOQUIM BIOL MOL | Address | 1 | 100% | 0% | 2 |
5 | ARGININE ASPARTATE | Author keyword | 1 | 50% | 0% | 2 |
6 | L ARGININE PARADOX | Author keyword | 1 | 50% | 0% | 2 |
7 | NITRITES BLOOD | Author keyword | 1 | 100% | 0% | 2 |
8 | VITAL STAT EPIDEMIOL | Address | 1 | 50% | 0% | 2 |
9 | INTERNAL MED METAB DISORDERS HYPERTENS | Address | 1 | 14% | 1% | 7 |
10 | CARDIODIABET CORE UNIT | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ORAL L ARGININE | 29 | 32% | 14% | 75 |
2 | DIETARY L ARGININE | 21 | 38% | 8% | 45 |
3 | HYPERCHOLESTEROLEMIC RABBIT | 8 | 24% | 5% | 28 |
4 | NITRIC OXIDE PRECURSOR | 7 | 67% | 1% | 6 |
5 | POTASSIUM MAGNESIUM ASPARTATE | 6 | 71% | 1% | 5 |
6 | HYPERCHOLESTEROLEMIC RABBITS | 5 | 12% | 8% | 43 |
7 | VASCULAR RELEASE | 2 | 38% | 1% | 5 |
8 | INHIBITS PLATELET AGGREGATION | 2 | 13% | 3% | 17 |
9 | ARGININE ASPARTATE | 2 | 67% | 0% | 2 |
10 | L NOMEGANITROARGININE | 1 | 50% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Effect of Nitric-Oxide-Related Supplements on Human Performance | 2012 | 26 | 100 | 29% |
Mechanisms of Disease: L-arginine in coronary atherosclerosis - a clinical perspective | 2007 | 29 | 53 | 62% |
Vascular effects of dietary L-arginine supplementation | 2002 | 63 | 56 | 71% |
L-Arginine as a Potential Ergogenic Aid in Healthy Subjects | 2011 | 19 | 106 | 40% |
L-arginine, the substrate for NO synthesis: An alternative treatment for premature atherosclerosis? | 2007 | 25 | 68 | 54% |
The Pharmacodynamics of L-Arginine | 2014 | 3 | 61 | 31% |
The clinical pharmacology of L-arginine | 2001 | 142 | 117 | 39% |
L-arginine and cardiovascular system | 2005 | 18 | 74 | 68% |
ROLE OF L-ARGININE IN NITRIC OXIDE PRODUCTION IN HEALTH AND HYPERTENSION | 2009 | 33 | 62 | 21% |
Nitric oxide and atherosclerosis | 2001 | 209 | 64 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BEIJING S HYDRONE PEPTIDES | 2 | 67% | 0.4% | 2 |
2 | CHAIR SEMEIOL MED METHODOL | 2 | 50% | 0.5% | 3 |
3 | ANAL AVANCADAS BIOQUIM BIOL MOL | 1 | 100% | 0.4% | 2 |
4 | VITAL STAT EPIDEMIOL | 1 | 50% | 0.4% | 2 |
5 | INTERNAL MED METAB DISORDERS HYPERTENS | 1 | 14% | 1.3% | 7 |
6 | CARDIODIABET CORE UNIT | 1 | 40% | 0.4% | 2 |
7 | BLOOD DEF SYST | 1 | 50% | 0.2% | 1 |
8 | CARDIODIABET TRIALS UNIT | 1 | 50% | 0.2% | 1 |
9 | CHAIR HYG HUMAN NUTR | 1 | 50% | 0.2% | 1 |
10 | CLIN TRIAL NORTH | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211987 | TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT |
2 | 0.0000190815 | CITRULLINE//HUBEI ANIM NUTR FEED SCI//HUNAN ENGN ANIM POULTRY SCI |
3 | 0.0000178792 | ASYMMETRIC DIMETHYLARGININE//ADMA//DIMETHYLARGININE DIMETHYLAMINOHYDROLASE |
4 | 0.0000129621 | FLOW MEDIATED DILATION//FLOW MEDIATED DILATATION//ENDOTHELIAL FUNCTION |
5 | 0.0000122049 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
6 | 0.0000119022 | ST EUGENIO CTO A ALESINI HOSP//CYCLIC GUANYLYL MONOPHOSPHATE//CIBER PATHOPHYSIOL OBES NUTR |
7 | 0.0000099671 | CYNOMORIUM SONGARICUM//CYNOMORIACEAE//CYNOMORIUM SONGARICUM RUPR |
8 | 0.0000078859 | ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE//ENOS GENE//ENOS POLYMORPHISM |
9 | 0.0000075631 | NORMAL PATHOL PHYSIOL//NO DEFICIENCY//L NAME HYPERTENSION |
10 | 0.0000074074 | ENDOTHELIAL RESPONSES//RADIAL ARTERY DIAMETER//RAPID VENTRICULAR PACING |